Step by Stepa HemeOncBuddy patient portal

Erlotinib

Illustration: Erlotinib

Say it: er-LOH-tih-nib · Brand names: Tarceva

Erlotinib is a targeted pill that blocks a growth signal in cancers with a change in the EGFR gene.

What it is

Some lung cancers have a change in a gene called EGFR. This change tells cancer cells to keep growing. Erlotinib blocks the EGFR signal, which can slow or shrink the cancer.

Often used for

How you get it

It is a pill you take by mouth once a day on an empty stomach. Take it at least 1 hour before or 2 hours after eating. Many people take it for a long time, as long as it works. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Erlotinib?
Erlotinib is a targeted pill that blocks a growth signal in cancers with a change in the EGFR gene. Brand names: Tarceva.
What is Erlotinib used for?
non-small cell lung cancer with certain EGFR gene changes; pancreatic cancer, together with the chemotherapy gemcitabine.
How is Erlotinib given?
It is a pill you take by mouth once a day on an empty stomach. Take it at least 1 hour before or 2 hours after eating. Many people take it for a long time, as long as it works. Your schedule may be different.
What are the common side effects of Erlotinib?
Rash or acne-like bumps on the face, chest, and back. Diarrhea. Loss of appetite. Feeling tired. Dry, itchy skin. Mouth sores. Nausea.
When should I call my care team while taking Erlotinib?
New or worse cough, shortness of breath, or chest pain, which can be a sign of lung swelling; Diarrhea that does not get better with the medicine your team told you to use, or 4 or more extra stools a day; Yellow skin or eyes, dark urine, or pain on the right side of your belly; Bad belly pain; Eye pain, red eyes, or changes in your vision; Skin that blisters or peels.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.